Apoptosis induced by overexpression of hMSH2 or hMLH1.

Mutations of the mismatch repair genes hMSH2 and hMLH1 have been found in a high proportion of individuals with hereditary nonpolyposis colon cancer (HNPCC), establishing the link between mismatch repair and cancer. Tumor cell lines that are deficient in mismatch repair develop a mutator phenotype that appears to drive the accumulation of mutations required for tumor development. However, mutations of other mismatch repair genes such as hPMS2 can lead to a mutator phenotype, although inherited mutations of these genes are rare in HNPCC families. Here, we show that overexpression of hMSH2 or hMLH1 but not of hMSH3, hMSH6, or hPMS2 induces apoptosis in either repair-proficient or -deficient cells. Furthermore, primary mouse embryo fibroblasts derived from Msh2-deficient mice lose their ability to undergo apoptosis after treatment with N-methyl-N'-nitro-N-nitrosoguanidine. These results suggest that the mismatch repair proteins hMSH2 and hMLH1 may be components of a pathway that influences apoptosis. We consider the possibility that loss of apoptosis as a result of hMSH2 or hMLH1 deficiency may be an additional factor in cancer predisposition in HNPCC.

[1]  T. DeWeese,et al.  Mouse embryonic stem cells carrying one or two defective Msh2 alleles respond abnormally to oxidative stress inflicted by low-level radiation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Fishel.  Mismatch repair, molecular switches, and signal transduction. , 1998, Genes & development.

[3]  T. Kunkel,et al.  Single gene complementation of the hPMS2 defect in HEC-1-A endometrial carcinoma cells. , 1998, Cancer research.

[4]  Bert Vogelstein,et al.  Mutations of mitotic checkpoint genes in human cancers , 1998, Nature.

[5]  Darryl Shibata,et al.  Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DMA mismatch repair , 1998, Nature Genetics.

[6]  J. Erhardt,et al.  p21WAF1 induces permanent growth arrest and enhances differentiation, but does not alter apoptosis in PC12 cells , 1998, Oncogene.

[7]  R. Fishel,et al.  The Human Mismatch Recognition Complex hMSH2-hMSH6 Functions as a Novel Molecular Switch , 1997, Cell.

[8]  J. Roth,et al.  p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells , 1997, Oncogene.

[9]  P. Modrich,et al.  DHFR/MSH3 amplification in methotrexate-resistant cells alters the hMutSα/hMutSβ ratio and reduces the efficiency of base–base mismatch repair , 1997 .

[10]  R. Bristow,et al.  Mutator phenotype in Msh2-deficient murine embryonic fibroblasts. , 1997, Cancer research.

[11]  A. Fornace,et al.  Role of p21Waf1/Cip1/Sdi1 in cell death and DNA repair as studied using a tetracycline-inducible system in p53-deficient cells , 1997, Oncogene.

[12]  J C Reed,et al.  Somatic Frameshift Mutations in the BAX Gene in Colon Cancers of the Microsatellite Mutator Phenotype , 1997, Science.

[13]  A. Destée,et al.  Long-term complementation of DNA repair deficient human primary fibroblasts by retroviral transduction of the XPD gene. , 1996, Mutation research.

[14]  G. Marsischky,et al.  hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[15]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[16]  Asad Umar,et al.  Requirement for PCNA in DNA Mismatch Repair at a Step Preceding DNA Resynthesis , 1996, Cell.

[17]  J. Jiricny,et al.  hMutSβ, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion loops in DNA , 1996, Current Biology.

[18]  K. Kinzler,et al.  APC mutations in colorectal tumors with mismatch repair deficiency. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  K. Kinzler,et al.  Apoptosis and APC in colorectal tumorigenesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  C. Harris,et al.  The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. , 1996, Genes & development.

[21]  R. Marcos,et al.  No increase in micronuclei frequency in cultured blood lymphocytes from a group of filling station attendants. , 1996, Mutation research.

[22]  G. Marsischky,et al.  Redundancy of Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch repair. , 1996, Genes & development.

[23]  T. Kunkel,et al.  Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines. , 1995, Cancer research.

[24]  T. Kunkel,et al.  Microsatellite instability in gynecological sarcomas and in hMSH2 mutant uterine sarcoma cell lines defective in mismatch repair activity. , 1995, Cancer research.

[25]  M. Oren,et al.  p53-independent death and p53-induced protection against apoptosis in fibroblasts treated with chemotherapeutic drugs. , 1995, British Journal of Cancer.

[26]  M. Hawn,et al.  Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint. , 1995, Cancer research.

[27]  Asad Umar,et al.  A hPMS2 Mutant Cell Line Is Defective in Strand-specific Mismatch Repair (*) , 1995, The Journal of Biological Chemistry.

[28]  J. Jiricny,et al.  GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. , 1995, Science.

[29]  P. Modrich,et al.  Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells. , 1995, Science.

[30]  K. Kinzler,et al.  Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. , 1995, Science.

[31]  P. Karran,et al.  DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines. , 1995, Cancer research.

[32]  P. Modrich,et al.  Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[33]  B. Vogelstein,et al.  Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancer. , 1995, Oncogene.

[34]  V. Lazar,et al.  Accumulation of multiple mutations in tumour suppressor genes during colorectal tumorigenesis in HNPCC patients. , 1994, Human molecular genetics.

[35]  R. Fleischmann,et al.  Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer , 1994, Nature.

[36]  M. Meuth,et al.  Mutator phenotypes in human colorectal carcinoma cell lines. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[37]  G. Hannon,et al.  The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA , 1994, Nature.

[38]  R. Fleischmann,et al.  Mutation of a mutL homolog in hereditary colon cancer. , 1994, Science.

[39]  D. Ward,et al.  Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer , 1994, Nature.

[40]  D. Shibata,et al.  Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation , 1994, Nature Genetics.

[41]  Bert Vogelstein,et al.  Hypermutability and mismatch repair deficiency in RER+ tumor cells , 1993, Cell.

[42]  Robin J. Leach,et al.  Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer , 1993, Cell.

[43]  N. Copeland,et al.  The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer , 1993, Cell.

[44]  W. Thilly,et al.  An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[45]  P. Shaw,et al.  Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[46]  A. Kimchi,et al.  Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 , 1991, Nature.

[47]  S. Reed,et al.  Stoichiometry of G protein subunits affects the Saccharomyces cerevisiae mating pheromone signal transduction pathway , 1990, Molecular and cellular biology.

[48]  M. Whiteway,et al.  Overexpression of the STE4 gene leads to mating response in haploid Saccharomyces cerevisiae , 1990, Molecular and cellular biology.

[49]  W. Thilly,et al.  Isolation and partial characterization of human cell mutants differing in sensitivity to killing and mutation by methylnitrosourea and N-methyl-N'-nitro-N-nitrosoguanidine. , 1986, The Journal of biological chemistry.

[50]  N. Papadopoulos,et al.  Molecular basis of HNPCC: Mutations of MMR genes , 1997, Human mutation.

[51]  Peter Beighton,et al.  de la Chapelle, A. , 1997 .

[52]  A. de la Chapelle,et al.  Genetics of hereditary colon cancer. , 1995, Annual review of genetics.